 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || levodopa/carbidopa ER (WD-1603) / China NT Pharma
New P1 trial: Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions (clinicaltrials.gov) - Nov 18, 2021
P1, N=15, Recruiting, Sponsor: Shanghai WD Pharmaceutical Co., Ltd.
- || levodopa/carbidopa ER (WD-1603) / China NT Pharma
Enrollment open: A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease (clinicaltrials.gov) - Oct 31, 2021
P2, N=40, Recruiting, Sponsor: Shanghai WD Pharmaceutical Co., Ltd.
Not yet recruiting --> Recruiting
- | levodopa/carbidopa ER (WD-1603) / China NT Pharma
New P2 trial: A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease (clinicaltrials.gov) - Sep 4, 2021
P2, N=40, Not yet recruiting, Sponsor: Shanghai WD Pharmaceutical Co., Ltd.
- || levodopa/carbidopa ER (WD-1603) / China NT Pharma
New P1 trial: PK Study of WD-1603 in Healthy Subjects (clinicaltrials.gov) - Oct 18, 2020
P1, N=8, Recruiting, Sponsor: Hong Kong WD Pharmaceutical Co., Limited
- || levodopa/carbidopa ER (WD-1603) / China NT Pharma
New P1 trial: A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions (clinicaltrials.gov) - Sep 17, 2020
P1, N=8, Not yet recruiting, Sponsor: Hong Kong WD Pharmaceutical Co., Limited
- || levodopa/carbidopa ER (WD-1603) / China NT Pharma
New P1 trial: WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects (clinicaltrials.gov) - Aug 13, 2020
P1, N=8, Recruiting, Sponsor: Hong Kong WD Pharmaceutical Co., Limited
- || levodopa/carbidopa ER (WD-1603) / China NT Pharma
Trial completion, Trial primary completion date: WD-1603 PK Study in Healthy Volunteers (clinicaltrials.gov) - Feb 13, 2020
P1, N=8, Completed, Sponsor: Hong Kong WD Pharmaceutical Co., Limited
Not yet recruiting --> Recruiting Not yet recruiting --> Completed | Trial primary completion date: Feb 2019 --> Sep 2019
- | levodopa/carbidopa ER (WD-1603) / China NT Pharma
New P1 trial: WD-1603 PK Study in Healthy Volunteers (clinicaltrials.gov) - Dec 3, 2018
P1, N=8, Not yet recruiting, Sponsor: Hong Kong WD Pharmaceutical Co., Limited